Skip to main content
MyCapitol LogoMyCapitol

HR 7658 · 117th Congress

To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

This bill extends and increases funding for a program that helps speed up the development of new medicines and medical treatments. The FDA currently runs something called the Critical Path Public-Private Partnerships, which brings together the government, pharmaceutical companies, medical device makers, and other he…

Sponsor
O'Halleran, Tom (D-AZ)
Introduced
2022-05-03
Policy area
Health
Latest action
Referred to the House Committee on Energy and Commerce.

Digging through Congress... 🔍